Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

September 22, 2016

Primary Completion Date

July 24, 2017

Study Completion Date

August 14, 2017

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Tiotropium

fixed dose combination once daily

DRUG

Olodaterol

fixed dose combination once daily

DRUG

Tiotropium

Trial Locations (13)

3000

UZ Leuven, Leuven

3500

Hasselt - PRAC Aumann, J-L, Hasselt

3600

Genk - PRAC Janssens, E., Genk

10787

Klinische Forschung Berlin GbR, Berlin

22927

Pneumologisches Forschungsinstitut an der LungenClinic Grosshansdorf GmbH, Großhansdorf

60596

IKF Pneumologie GmbH & Co. KG, Frankfurt am Main

L8N 3Z5

McMaster Univ. Medical Centre, Hamilton

K7L 2V7

Kingston General Hospital, Kingston

H4A 3J1

McGill University Health Centre (MUHC), Montreal

G1V 4G5

IUCPQ (Laval University), Québec

5623 EJ

Catharina Ziekenhuis, Eindhoven

6419 PC

Zuyderland Medisch Centrum, Heerlen

7207 AE

Gelre Ziekenhuis Zutphen, Zutphen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY